Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Issues / 2016 / Articles / Feb / Insolubility Insight
Discovery & Development Drug Delivery Formulation Formulation

Insolubility Insight

02/26/2016 1 min read

Share

Solubility is a key concern for any drug delivery system or technology. Unfortunately, industry pipelines are full of compounds with poor solubility and poor permeability – and it’s unlikely that the problem will ever be completely eliminated.  Pharmaceutical pipelines full of poorly soluble and poorly permeable compounds present significant challenges for established delivery platforms, particularly transdermal drug delivery and controlled release technologies, driving a growing interest in more innovative drug delivery methods. As such, many poorly soluble compounds are formulated as immediate release drug products to first improve the aqueous solubility of the API. Switching these to controlled release requires significant innovation because achieving both solubilization and controlled release is not straightforward. Nevertheless, solving these challenges is critical when it comes to managing the lifecycle of poorly soluble products.

Traditional approaches to improve drug solubility include drug-salt formation, complexation and polymorph selection; however we are seeing a growing number of compounds that are so insoluble that these standard techniques are inadequate. This has led to new formulation approaches for the pharmaceutical industry; for example, the application of amorphous solid dispersion techniques such as spray drying and hot melt extrusion and development of novel polymers that are specifically designed for these processes. Matching an API to the optimal solubility enhancement technology is challenging due to the great variety of available polymers, techniques and the complexity of pipeline APIs and difficulties in predicting polymer-API interactions. That’s why we often see companies taking multiple formulations into early phase development – if one candidate fails, there’s another to take its place. We also advise companies to consider the impact of polymer variability on final product performance – a Quality-by-Design approach to polymer properties and their impact on performance helps ensure robust performance of the finished product.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

Managing Change in Devices for Patients
Drug Delivery
Managing Change in Devices for Patients

June 21, 2024

4 min read

We need to step away from assumptions on device interchangeability and find out what patients really want

Dosing to Circadian Rhythm
Drug Delivery
Dosing to Circadian Rhythm

December 1, 2014

0 min read

Could medicines be made more effective with better timing?

Connecting the Dots in Drug Delivery
Drug Delivery
Connecting the Dots in Drug Delivery

December 1, 2014

0 min read

The days of “low-hanging fruit” in drug discovery are a thing of the past...

Squid-Inspired Drug Delivery
Drug Delivery Dosage Forms Formulation
Squid-Inspired Drug Delivery

April 3, 2025

4 min read

Here’s how researchers took lessons from cephalopods to develop a new capsule that can deliver drugs, including insulin and siRNA, orally

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.